Back to Market Feed

Product Information

CLOCORTOLONE PIVALATE 0.1% CRM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $5.2105 per GM under NDC 51672416606. Its NADAC has been published 170 times since Nov 23, 2022.

FDA first approved this application on Apr 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOCORTOLONE PIVALATE 0.1% CRM

Clocortolone Pivalate
$5.2105per GM

Strength

.001 g/g

NDC

51672416606

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

7/23/2025

Active Ingredients

CLOCORTOLONE PIVALATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206370

FDA Approved

4/21/2020

TE Code

AB

On Market Since

4/21/2020

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has been published 170 times since Nov 23, 2022, and over the history we have for it it has risen 31.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.2105 per GM
All-time high$5.2116 (May 14, 2025)
All-time low$2.8680 (May 22, 2024)
52-week high$5.2105
52-week low$5.2105
Median price$3.9689
Average price$4.3020
Largest weekly change+18.5% (Jun 19, 2024)
Weeks tracked170
Tracking sinceNov 23, 2022

Price History

1W

N/A

1M

N/A

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+31.3%

5Y

N/A

All

+31.3%

Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clocortolone Pivalate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TRIAMCINOLONE 0.1% CREAM
Generic
00168000416•E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
$0.0247
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
16714098604•NorthStar Rx LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
21922006230•Encube Ethicals, Inc.
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
33342032954•Macleods Pharmaceuticals Limited
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
45802006405•Padagis Israel Pharmaceuticals Ltd
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
52817081154•TruPharma LLC
$0.0280
per GM
TRIAMCINOLONE 0.1% CREAM
Generic
67877025145•Ascend Laboratories, LLC
$0.0280
per GM
DEXAMETHASONE 0.5 MG/5 ML LIQ
Generic
00054317763•Hikma Pharmaceuticals USA Inc.
$0.0293
per ML
TRIAMCINOLONE 0.1% CREAM
Generic
68462013159•Glenmark Pharmaceuticals Inc., USA
$0.0300
per GM
TRIAMCINOLONE 0.1% OINTMENT
Generic
16714027603•NorthStar Rx LLC
$0.0348
per GM

Frequently asked questions

What is the NADAC price of CLOCORTOLONE PIVALATE 0.1% CRM?

The current National Average Drug Acquisition Cost (NADAC) for CLOCORTOLONE PIVALATE 0.1% CRM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $5.2105 per GM (NDC 51672416606), effective Jul 15, 2026.

How has the price of CLOCORTOLONE PIVALATE 0.1% CRM changed over time?

Over the history we have for it, the NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has risen 31.3%. It has been tracked across 170 weekly CMS publications since Nov 23, 2022.

What are the highest and lowest recorded NADAC prices for CLOCORTOLONE PIVALATE 0.1% CRM?

Since Nov 23, 2022, the NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has ranged from a low of $2.8680 (May 22, 2024) to a high of $5.2116 (May 14, 2025), with a median of $3.9689 per GM.

Are there cheaper alternatives to CLOCORTOLONE PIVALATE 0.1% CRM?

No other NADAC-published product currently shares the active ingredient and strength of CLOCORTOLONE PIVALATE 0.1% CRM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLOCORTOLONE PIVALATE 0.1% CRM?

CLOCORTOLONE PIVALATE 0.1% CRM (NDC 51672416606) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.